Detalhe da pesquisa
1.
Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19.
Front Immunol
; 12: 766112, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34938290